AbolerIS Pharma
AbolerIS Pharma develops immuno-modulators as treatments for transplant rejection, graft-versus-host disease, and auto-immune diseases.
Company details
- Website
- aboleris-pharma.com
- Location
- Nantes, France
- Founded
- 2019
- Employees
- 11-50
- Last funding round
- Series A
- Verified emails available
- 0
Key people at AbolerIS Pharma
- Dr. Carole Guillonneau, Co-Founder and Head of Research
- Dr. Ignacio Anegon, Co-Founder, Senior Consultant, and SAB Member
- Dr. François-Xavier Hubert, Co-Founder
Reveal AbolerIS Pharma's verified founder emails on FindMeMail (free account, 50 free reveals).
Frequently asked questions
What is AbolerIS Pharma?
AbolerIS Pharma develops immuno-modulators as treatments for transplant rejection, graft-versus-host disease, and auto-immune diseases.
Who are the key people at AbolerIS Pharma?
Dr. Carole Guillonneau (Co-Founder and Head of Research), Dr. Ignacio Anegon (Co-Founder, Senior Consultant, and SAB Member), Dr. François-Xavier Hubert (Co-Founder).
How do I find the email address of AbolerIS Pharma's founder?
FindMeMail does not have a verified email for AbolerIS Pharma yet. You can try the Email Finder at findmemail.io/email-finder.